Complement activation and cardiac surgery: a novel target for improving outcomes.

Other Article (Journal Article;Review)

Complement activation and the resulting inflammatory response is an important potential mechanism for multisystem organ injury in cardiac surgery. Novel therapeutic strategies using complement inhibitors may hold promise for improving outcomes for cardiac surgical patients by attenuating complement activation or its biologically active effector molecules. Recent clinical trials evaluating complement inhibitors have provided important data to further delineate the impact of complement activation and its inhibition on clinical outcomes. In this review we examine the role of complement activation and its inhibition as a therapeutic approach in cardiac surgery.

Full Text

Duke Authors

Cited Authors

  • Stahl, GL; Shernan, SK; Smith, PK; Levy, JH

Published Date

  • October 2012

Published In

Volume / Issue

  • 115 / 4

Start / End Page

  • 759 - 771

PubMed ID

  • 22798530

Pubmed Central ID

  • 22798530

Electronic International Standard Serial Number (EISSN)

  • 1526-7598

Digital Object Identifier (DOI)

  • 10.1213/ANE.0b013e3182652b7d

Language

  • eng

Conference Location

  • United States